GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Instem PLC (LSE:INS) » Definitions » Total Liabilities

Instem (LSE:INS) Total Liabilities : £29.01 Mil (As of Jun. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Instem Total Liabilities?

Instem's Total Liabilities for the quarter that ended in Jun. 2023 was £29.01 Mil.

Instem's quarterly Total Liabilities increased from Jun. 2022 (£35.81 Mil) to Dec. 2022 (£39.35 Mil) but then declined from Dec. 2022 (£39.35 Mil) to Jun. 2023 (£29.01 Mil).

Instem's annual Total Liabilities increased from Dec. 2020 (£20.53 Mil) to Dec. 2021 (£43.88 Mil) but then declined from Dec. 2021 (£43.88 Mil) to Dec. 2022 (£39.35 Mil).


Instem Total Liabilities Historical Data

The historical data trend for Instem's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Instem Total Liabilities Chart

Instem Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.75 18.00 20.53 43.88 39.35

Instem Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.28 43.88 35.81 39.35 29.01

Instem Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Instem's Total Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=34.902+(0.491+1.946
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+2.013)
=39.35

Total Liabilities=Total Assets (A: Dec. 2022 )-Total Equity (A: Dec. 2022 )
=92.709-53.357
=39.35

Instem's Total Liabilities for the quarter that ended in Jun. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=25.501+(0.477+1.658
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+1.375)
=29.01

Total Liabilities=Total Assets (Q: Jun. 2023 )-Total Equity (Q: Jun. 2023 )
=83.652-54.641
=29.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Instem Total Liabilities Related Terms

Thank you for viewing the detailed overview of Instem's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Instem (LSE:INS) Business Description

Traded in Other Exchanges
N/A
Address
Diamond Way, Stone Business Park, Stone, Staffordshire, GBR, ST15 0SD
Instem PLC acts as a supplier of IT applications and technology-enabled outsourced services to the global health and life sciences community. Its segments include Study Management, Regulatory Solutions, and In Silico Solutions, Clinical Trial Acceleration. The company generates maximum revenue from Study Management. Geographically, it derives a majority of its revenue from the United States and also has a presence in the Europe and Rest of the World. Its portfolio of software solutions includes Instem Cloud, SEND Data Conversion, KnowledgeScan, SENDReady Consulting, Solution Deployment, Validation, Data Management, and Regulatory Information Management.

Instem (LSE:INS) Headlines

No Headlines